A citation-based method for searching scientific literature

Romain Nardou, Eastman M Lewis, Rebecca Rothhaas, Ran Xu, Aimei Yang, Edward Boyden, Gül Dölen. Nature 2019
Times Cited: 90







List of co-cited articles
1022 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin.
Gül Dölen, Ayeh Darvishzadeh, Kee Wui Huang, Robert C Malenka. Nature 2013
634
33

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
283
21

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin. Psychopharmacology (Berl) 2019
121
18

Gating of social reward by oxytocin in the ventral tegmental area.
Lin W Hung, Sophie Neuner, Jai S Polepalli, Kevin T Beier, Matthew Wright, Jessica J Walsh, Eastman M Lewis, Liqun Luo, Karl Deisseroth, Gül Dölen,[...]. Science 2017
245
18

MDMA enhances emotional empathy and prosocial behavior.
Cédric M Hysek, Yasmin Schmid, Linda D Simmler, Gregor Domes, Markus Heinrichs, Christoph Eisenegger, Katrin H Preller, Boris B Quednow, Matthias E Liechti. Soc Cogn Affect Neurosci 2014
153
16

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Alicia L Danforth, Charles S Grob, Christopher Struble, Allison A Feduccia, Nick Walker, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson. Psychopharmacology (Berl) 2018
69
21

MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Allison A Feduccia, Michael C Mithoefer. Prog Neuropsychopharmacol Biol Psychiatry 2018
70
20


MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot'alora G, Wael Garas, Casey Paleos, Ingmar Gorman,[...]. Nat Med 2021
141
14

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
583
13

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
511
13

Oxytocin enables maternal behaviour by balancing cortical inhibition.
Bianca J Marlin, Mariela Mitre, James A D'amour, Moses V Chao, Robert C Froemke. Nature 2015
363
12

Oxytocin Enhances Social Recognition by Modulating Cortical Control of Early Olfactory Processing.
Lars-Lennart Oettl, Namasivayam Ravi, Miriam Schneider, Max F Scheller, Peggy Schneider, Mariela Mitre, Miriam da Silva Gouveia, Robert C Froemke, Moses V Chao, W Scott Young,[...]. Neuron 2016
185
11

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Mark T Wagner, Michael C Mithoefer, Ann T Mithoefer, Rebecca K MacAulay, Lisa Jerome, Berra Yazar-Klosinski, Rick Doblin. J Psychopharmacol 2017
48
20

Subjective reports of the effects of MDMA in a clinical setting.
G Greer, R Tolbert. J Psychoactive Drugs 1986
261
11


Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb,[...]. J Psychopharmacol 2016
484
11

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, P C R Barbosa, Rick J Strassman. J Psychopharmacol 2015
399
11

Distinct neural mechanisms for the prosocial and rewarding properties of MDMA.
Boris D Heifets, Juliana S Salgado, Madison D Taylor, Paul Hoerbelt, Daniel F Cardozo Pinto, Elizabeth E Steinberg, Jessica J Walsh, Ji Y Sze, Robert C Malenka. Sci Transl Med 2019
38
26

The neurobiology of pair bonding.
Larry J Young, Zuoxin Wang. Nat Neurosci 2004
871
10

5-HT release in nucleus accumbens rescues social deficits in mouse autism model.
Jessica J Walsh, Daniel J Christoffel, Boris D Heifets, Gabriel A Ben-Dor, Aslihan Selimbeyoglu, Lin W Hung, Karl Deisseroth, Robert C Malenka. Nature 2018
94
10

Psychedelics.
David E Nichols. Pharmacol Rev 2016
500
10

Oxytocin in the medial amygdala is essential for social recognition in the mouse.
J N Ferguson, J M Aldag, T R Insel, L J Young. J Neurosci 2001
666
8

The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
Anya K Bershad, Melissa A Miller, Matthew J Baggott, Harriet de Wit. J Psychopharmacol 2016
49
16

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
Michael C Mithoefer, Mark T Wagner, Ann T Mithoefer, Lisa Jerome, Scott F Martin, Berra Yazar-Klosinski, Yvonne Michel, Timothy D Brewerton, Rick Doblin. J Psychopharmacol 2013
210
8

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
8

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.
Robin L Carhart-Harris, Kevin Murphy, Robert Leech, David Erritzoe, Matthew B Wall, Bart Ferguson, Luke T J Williams, Leor Roseman, Stefan Brugger, Ineke De Meer,[...]. Biol Psychiatry 2015
71
11

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Michael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, Lisa Jerome, Mark Wagner, Joy Wymer, Julie Holland, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson,[...]. Lancet Psychiatry 2018
153
8

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
A Richard Green, Annis O Mechan, J Martin Elliott, Esther O'Shea, M Isabel Colado. Pharmacol Rev 2003
821
8

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.
Matthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, Roland R Griffiths. J Psychopharmacol 2014
340
8


Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Lisa Jerome, Allison A Feduccia, Julie B Wang, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Michael C Mithoefer, Rick Doblin. Psychopharmacology (Berl) 2020
42
19

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.
Michael C Mithoefer, Charles S Grob, Timothy D Brewerton. Lancet Psychiatry 2016
122
7

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning.
M B Young, R Andero, K J Ressler, L L Howell. Transl Psychiatry 2015
53
13

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
7

Effects of MDMA on sociability and neural response to social threat and social reward.
Gillinder Bedi, K Luan Phan, Mike Angstadt, Harriet de Wit. Psychopharmacology (Berl) 2009
111
7

MDMA alters emotional processing and facilitates positive social interaction.
Margaret C Wardle, Harriet de Wit. Psychopharmacology (Berl) 2014
46
15

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.
Roland R Griffiths, Matthew W Johnson, William A Richards, Brian D Richards, Robert Jesse, Katherine A MacLean, Frederick S Barrett, Mary P Cosimano, Maggie A Klinedinst. J Psychopharmacol 2018
133
7

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.
Roland R Griffiths, Matthew W Johnson, William A Richards, Brian D Richards, Una McCann, Robert Jesse. Psychopharmacology (Berl) 2011
319
7


Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.
Peter Gasser, Dominique Holstein, Yvonne Michel, Rick Doblin, Berra Yazar-Klosinski, Torsten Passie, Rudolf Brenneisen. J Nerv Ment Dis 2014
277
7

Hippocampal oxytocin receptors are necessary for discrimination of social stimuli.
Tara Raam, Kathleen M McAvoy, Antoine Besnard, Alexa H Veenema, Amar Sahay. Nat Commun 2017
132
7

Social reward among juvenile mice.
J B Panksepp, G P Lahvis. Genes Brain Behav 2007
160
7

Volitional social interaction prevents drug addiction in rat models.
Marco Venniro, Michelle Zhang, Daniele Caprioli, Jennifer K Hoots, Sam A Golden, Conor Heins, Marisela Morales, David H Epstein, Yavin Shaham. Nat Neurosci 2018
154
7

Biased Oxytocinergic Modulation of Midbrain Dopamine Systems.
Lei Xiao, Michael F Priest, Jordan Nasenbeny, Ting Lu, Yevgenia Kozorovitskiy. Neuron 2017
132
7

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats.
Holly S Hake, Jazmyne K P Davis, River R Wood, Margaret K Tanner, Esteban C Loetz, Anais Sanchez, Mykola Ostrovskyy, Erik B Oleson, Jim Grigsby, Rick Doblin,[...]. Physiol Behav 2019
20
35

Natural neural projection dynamics underlying social behavior.
Lisa A Gunaydin, Logan Grosenick, Joel C Finkelstein, Isaac V Kauvar, Lief E Fenno, Avishek Adhikari, Stephan Lammel, Julie J Mirzabekov, Raag D Airan, Kelly A Zalocusky,[...]. Cell 2014
693
7

Dendritic peptide release and peptide-dependent behaviours.
Mike Ludwig, Gareth Leng. Nat Rev Neurosci 2006
620
6

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.
Karen J Parker, Ozge Oztan, Robin A Libove, Raena D Sumiyoshi, Lisa P Jackson, Debra S Karhson, Jacqueline E Summers, Kyle E Hinman, Kara S Motonaga, Jennifer M Phillips,[...]. Proc Natl Acad Sci U S A 2017
163
6

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
Marcela Ot'alora G, Jim Grigsby, Bruce Poulter, Joseph W Van Derveer, Sara Gael Giron, Lisa Jerome, Allison A Feduccia, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson,[...]. J Psychopharmacol 2018
66
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.